Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel measurements in LFLG aortic stenosis undergoing TAVI
NCT05196815Completed
- Sponsor
- The Royal Wolverhampton NHS Trust
- Start
- Jul 2022
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in aortic valve stenosis, sponsored by The Royal Wolverhampton NHS Trust. Primary endpoints: Change in Left Ventricular Ejection Fraction at 3 months, Change in Left Ventricular Volume at 3 months and 5 more. Started Jul 2022; status: completed.
02
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT05196815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05196815.